Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (1.021)

1

Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis : an open-label study

enthalten in: Rheumatology (Oxford, England) | 2024

von Wang, J. | Kong, X. | Ma, L. | +7

2

Comment on : Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Misra, D.

3

Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs

enthalten in: The Journal of rheumatology | 2024

von Ruscitti, P. | McGonagle, D. | Garcia, V. | +9

4

Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia

enthalten in: Clinical rheumatology | 2024

von An, Q. | Ma, R. | Yuan, D. | +8

5

Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study) : a multicenter, post-marketing, non-interventional, observational trial

enthalten in: Clinical rheumatology | 2024

von Athanassiou, P. | Katsimbri, P. | Bounas, A. | +23

6

Towards the Lowest Efficacious Dose : Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Kedra, J. | Dieudé, P. | Giboin, C. | +133

7

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept : Results from the international TOCERRA and PANABA observational collaborative studies

enthalten in: Joint bone spine | 2024

von Lauper, K. | Mongin, D. | Bergstra, S. | +20

8

Risk of hospitalized infections in older elderly patients with rheumatoid arthritis treated with tocilizumab or other biological/targeted synthetic disease-modifying antirheumatic drugs : Evaluation of data from a Japanese claims database

enthalten in: Modern rheumatology | 2024

von Harigai, M. | Fujii, T. | Sakai, R. | +9

ErratumIn: Mod Rheumatol. 2023 May 24;:. - PMID 37225887

9

Comparison of the efficacy and safety of tocilizumab, sarilumab, and olokizumab in patients with active rheumatoid arthritis : a network meta-analysis of randomized controlled trials

enthalten in: Zeitschrift fur Rheumatologie | 2024

von Ho Lee, Y. | Gyu Song, G.

10

Comparison of the efficacy and safety of a proposed biosimilar MSB11456 with tocilizumab reference product in subjects with moderate-to-severe rheumatoid arthritis : results of a randomised double-blind study

enthalten in: RMD open | 2024

von Zubrzycka-Sienkiewicz, A. | Klama, K. | Ullmann, M. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[103]